SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Royalty Pharma Q3 Results Expected November 4

Royalty Pharma is scheduled to report Q3'26 results before the market opens on November 4.

RPRX
SquawkNews Desk

RPRX (Royalty Pharma plc) is set to announce its Q3'26 results on November 04, before the market opens. The earnings are expected to be disclosed at 7:00 AM ET (12:00 PM UTC).For Q3'26, revenue estimate is 884.84 million USD with EPS (earnings per share) anticipated at 1.18 USD. Learn more details…

Related stories

Embassy Developments Reports Q2 Consolidated Net Profit M impact | EQUITY | Nov 03, 2026, 01:49 PM UTC Bosch to Establish Dedicated Semiconductor Division Germany's Robert Bosch said it would establish a dedicated semiconductor division as demand for chips used in data centers and humanoid robots surges. L impact | EQUITY | Nov 03, 2026, 01:49 PM UTC Galleon Gold Raises CAD 37 Million in Private Placements Galleon Gold raised CAD 37 million through private placements. M impact | EQUITY | Nov 03, 2026, 01:48 PM UTC Embassy Developments Q2 Revenue From Operations INR 2,922.1 Million M impact | EQUITY | Nov 03, 2026, 01:48 PM UTC Galleon Gold Closes Upsized $30M Private Placement and $7M Concurrent Offering Galleon Gold says it closed an upsized $30 million bought deal private placement, including full exercise of the over-allotment option, alongside a $7 million non-brokered private M impact | EQUITY | Nov 03, 2026, 01:47 PM UTC CIRO halts trading in ACB CIRO says trading in Aurora Cannabis shares has been halted. M impact | EQUITY | Nov 03, 2026, 01:47 PM UTC